Q3 2025 Holdings
Filed 2025-11-14 | 9 holdings | $492.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rapport Therapeutics Inc.(RAPP) | COM | 75383L102 | $110.7M | 3,728,738 | 22.5% |
| Beam Therapeutics Inc.(BEAM) | COM | 07373V105 | $110.2M | 4,540,132 | 22.4% |
| Maze Therapeutics Inc.(MAZE) | COM | 578784100 | $106.8M | 4,120,053 | 21.7% |
| VIR Biotechnology Inc.(VIR) | COM | 92764N102 | $73.8M | 12,916,663 | 15.0% |
| Lyell Immunopharma Inc.(LYEL) | COM NEW | 55083R203 | $44.8M | 2,759,072 | 9.1% |
| Erasca Inc.(ERAS) | COM | 29479A108 | $24.1M | 11,055,554 | 4.9% |
| Gossamer BIO Inc.(GOSS) | COM | 38341P102 | $21.2M | 8,055,916 | 4.3% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $634.6K | 320,482 | 0.1% |
| Cero Therapeutics Holdings Inc.(CERO) | COM | 71902K402 | $114.0K | 22,389 | 0.0% |